378 related articles for article (PubMed ID: 20482298)
1. Non-invasive fetal RHD genotyping in the first trimester of pregnancy.
Cardo L; García BP; Alvarez FV
Clin Chem Lab Med; 2010 Aug; 48(8):1121-6. PubMed ID: 20482298
[TBL] [Abstract][Full Text] [Related]
2. Non-invasive fetal RHD exon 7 and exon 10 genotyping using real-time PCR testing of fetal DNA in maternal plasma.
Hromadnikova I; Vechetova L; Vesela K; Benesova B; Doucha J; Kulovany E; Vlk R
Fetal Diagn Ther; 2005; 20(4):275-80. PubMed ID: 15980640
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic accuracy of fetal rhesus D genotyping using cell-free fetal DNA during the first trimester of pregnancy.
Vivanti A; Benachi A; Huchet FX; Ville Y; Cohen H; Costa JM
Am J Obstet Gynecol; 2016 Nov; 215(5):606.e1-606.e5. PubMed ID: 27393271
[TBL] [Abstract][Full Text] [Related]
4. Determination of fetal RHD type in plasma of RhD negative pregnant women.
Sørensen K; Kjeldsen-Kragh J; Husby H; Akkök ÇA
Scand J Clin Lab Invest; 2018 Sep; 78(5):411-416. PubMed ID: 29869532
[TBL] [Abstract][Full Text] [Related]
5. [Antenatal determination of fetal RhD-blood type based on fetal DNA in plasma from the RhD-negative mother--secondary publication].
Clausen FB; Krog GR; Rieneck K; Nielsen LK; Lundquist R; Finning K; Dickmeiss E; Hedegaard M; Dziegiel MH
Ugeskr Laeger; 2006 Jun; 168(26-32):2568-70. PubMed ID: 16824414
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of RhD status and clinical application of non-invasive prenatal determination of fetal RHD in maternal plasma: a 5 year experience in Cyprus.
Papasavva T; Martin P; Legler TJ; Liasides M; Anastasiou G; Christofides A; Christodoulou T; Demetriou S; Kerimis P; Kontos C; Leontiades G; Papapetrou D; Patroclos T; Phylaktou M; Zottis N; Karitzie E; Pavlou E; Kountouris P; Veldhuisen B; van der Schoot E; Kleanthous M
BMC Res Notes; 2016 Apr; 9():198. PubMed ID: 27036548
[TBL] [Abstract][Full Text] [Related]
7. Polymerase-chain-reaction-based detection of fetal rhesus D and Y-chromosome-specific DNA in the whole blood of pregnant women during different trimesters of pregnancy.
Al-Yatama MK; Mustafa AS; Al-Kandari FM; Khaja N; Zohra K; Monem RA; Abraham S
Med Princ Pract; 2007; 16(5):327-32. PubMed ID: 17709918
[TBL] [Abstract][Full Text] [Related]
8. Reliable test for prenatal prediction of fetal RhD type using maternal plasma from RhD negative women.
Clausen FB; Krog GR; Rieneck K; Nielsen LK; Lundquist R; Finning K; Dickmeiss E; Hedegaard M; Dziegiel MH
Prenat Diagn; 2005 Nov; 25(11):1040-4. PubMed ID: 16231312
[TBL] [Abstract][Full Text] [Related]
9. Fetal RhD genotyping by real time quantitative PCR in maternal plasma of RhD-negative pregnant women from the Sahel of Tunisia.
Moussa H; Tsochandaridis M; Jemni-Yacoub S; Hmida S; Khairi H; Gabert J; Levy-Mozziconacci A
Ann Biol Clin (Paris); 2012; 70(6):683-8. PubMed ID: 23207814
[TBL] [Abstract][Full Text] [Related]
10. First trimester noninvasive fetal RHD genotyping using maternal dried blood spots.
Xiong Y; Jeronis S; Hoffman B; Liebermann DA; Geifman-Holtzman O
Prenat Diagn; 2017 Apr; 37(4):311-317. PubMed ID: 28081297
[TBL] [Abstract][Full Text] [Related]
11. Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma.
Lo YM; Hjelm NM; Fidler C; Sargent IL; Murphy MF; Chamberlain PF; Poon PM; Redman CW; Wainscoat JS
N Engl J Med; 1998 Dec; 339(24):1734-8. PubMed ID: 9845707
[TBL] [Abstract][Full Text] [Related]
12. Noninvasive fetal RhD status determination in early pregnancy.
Manzanares S; Entrala C; Sánchez-Gila M; Fernández-Rosado F; Cobo D; Martinez E; Molina L; Reche R; Pineda A; Gallo JL
Fetal Diagn Ther; 2014; 35(1):7-12. PubMed ID: 24335165
[TBL] [Abstract][Full Text] [Related]
13. Noninvasive fetal RHD genotyping from maternal plasma. Use of a new developed Free DNA Fetal Kit RhD.
Rouillac-Le Sciellour C; Sérazin V; Brossard Y; Oudin O; Le Van Kim C; Colin Y; Guidicelli Y; Menu M; Cartron JP
Transfus Clin Biol; 2007 Dec; 14(6):572-7. PubMed ID: 18375165
[TBL] [Abstract][Full Text] [Related]
14. Use of free fetal DNA in prenatal noninvasive detection of fetal RhD status and fetal gender by molecular analysis of maternal plasma.
Sedrak M; Hashad D; Adel H; Azzam A; Elbeltagy N
Genet Test Mol Biomarkers; 2011 Sep; 15(9):627-31. PubMed ID: 21488716
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of non-invasive prenatal RHD genotyping of the fetus.
Hyland CA; Gardener GJ; Davies H; Ahvenainen M; Flower RL; Irwin D; Morris JM; Ward CM; Hyett JA
Med J Aust; 2009 Jul; 191(1):21-5. PubMed ID: 19580531
[TBL] [Abstract][Full Text] [Related]
16. [Non invasive fetal RhD genotyping using maternal blood: time for use in all RhD negative pregnant women].
Carbonne B; Cortey A; Rouillac-Le Sciellour C; Brossard Y
Gynecol Obstet Fertil; 2008 Feb; 36(2):200-203. PubMed ID: 18243756
[TBL] [Abstract][Full Text] [Related]
17. Fetal RHD genotyping in maternal plasma at 11-13 weeks of gestation.
Akolekar R; Finning K; Kuppusamy R; Daniels G; Nicolaides KH
Fetal Diagn Ther; 2011; 29(4):301-6. PubMed ID: 21212654
[TBL] [Abstract][Full Text] [Related]
18. RHD genotyping from maternal plasma: guidelines and technical challenges.
Avent ND
Methods Mol Biol; 2008; 444():185-201. PubMed ID: 18425481
[TBL] [Abstract][Full Text] [Related]
19. Noninvasive fetal RHD genotyping from maternal plasma in an admixed Brazilian population.
Schmidt LC; Cabral AC; Faria MA; Monken F; Tarazona-Santos E; Martins ML
Genet Mol Res; 2014 Feb; 13(1):799-805. PubMed ID: 24615044
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic accuracy of non-invasive fetal RhD genotyping using cell-free fetal DNA: a meta analysis.
Zhu YJ; Zheng YR; Li L; Zhou H; Liao X; Guo JX; Yi P
J Matern Fetal Neonatal Med; 2014 Dec; 27(18):1839-44. PubMed ID: 24422551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
